Ryght AI and Cancer Research SA (CRSA) Partner to Enhance Cancer Clinical Trials in South Australia
LAGUNA BEACH, Calif., Jan. 28, 2025 /PRNewswire/ — Ryght AI, a leading provider of real-time generative AI solutions for the clinical research industry, and Cancer Research South Australia (CRSA), a premier cancer care provider, have announced a strategic partnership to advance cancer clinical trials in South Australia. Through this collaboration, CRSA will join the Ryght Research Network, leveraging Ryght AI’s cutting-edge technology to optimize and accelerate clinical trials for people with cancer. This collaboration marks a significant step forward in improving access to novel cancer therapies for patients in South Australia. By integrating Ryght AI’s cutting-edge AI-powered solutions with CRSA’s expertise in cancer care and clinical trials, the partnership aims to streamline clinical trial processes, minimize administrative challenges, and connect South Australia with novel therapies from Ryght’s network of trial sponsors and CROs. This effort is focused on delivering life-saving treatments to patients more efficiently and effectively.
